New York City, NY -- (SBWIRE) -- 12/11/2013 -- StockMarketIntel.com issues a special report on the following stocks: MONITISE PLC (OTCMKTS:MONIF), IntelGenx Technologies Corp. (OTCMKTS:IGXT), Nuvilex Inc (OTCMKTS:NVLX), LONZA GROUP AG (OTCMKTS:LZAGY)
MONITISE PLC (OTCMKTS:MONIF) declined -1.36% recently, while trading on 446,677 shares, at the price of $0.900. The stock changed hands in a range of $0.90 to $0.92 up till now, bringing its market capitalization at about $1.50 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.47 and was moved to the maximum level of $1.00.
Has MONIF Found The Bottom and Ready To Move Up? Find Out Here
IntelGenx Technologies Corp. (OTCMKTS:IGXT) declined -0.20% recently in the current trading session, at $0.490 with a total volume of 31,020 shares. The stock, on average, trades on a volume of 122,372 shares. In the past 52 weeks, the share price has not declined below $0.45 and above $0.75.It floated in a range of $0.49 to $0.50 during the recent trading session, with a beta value of 33.14.Its market capitalization now moved to about $25.14 million. IntelGenx Technologies Corp., a drug delivery company, engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Its product portfolio comprises INT0001/2004 for coronary heart failure and hypertension; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2007 for the treatment of migraine.
Why Should Investors Buy IGXT After the Recent Fall? Just Go Here and Find Out
Nuvilex Inc (OTCMKTS:NVLX) recently added 0.71% and was moving within a range of $0.13-$0.13, its current trading price is $0.127. The stock is moving up till now with a total volume of 748,298 shares, versus an average volume of 1.52 million shares. The share price hit its 52-week low of $0.02 and $0.22 was the best price. Nuvilex, Inc, a biotechnology and life technology company, develops and markets products to improve the health, condition, and well-being. The company offers Cinnechol, a natural supplement, which helps in maintaining normal cholesterol levels and supports normal cardiovascular function; Cinnergen, a liquid whole food nutritional supplement that provides nutrients to help the body process glucose.
Why Should Investors Buy NVLX After The Recent Gain? Just Go Here and Find Out
LONZA GROUP AG (OTCMKTS:LZAGY) declined -0.45% in its current trading activity, bringing its market capitalization around $4.74 billion. The share price, after opening at $8.98, hit a high of $8.98 and hovered above $8.91, while its recent trading price was $8.91. The total number of shares changed hands during the current session up till now was 1,340 shares, as compared to average trading volume of 45,306 shares. Lonza Group AG supplies products and services to the pharmaceutical and biotechnology, healthcare, and life-science industries worldwide. Its Custom Manufacturing segment manufactures active ingredients that are used in critical drugs for treating patients with cardiovascular diseases, cancer, neurological, and infectious diseases.
Will LZAGY Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)